ACM Research, Inc. Class A Common Stock
ACMR
$94.08
-8.66%
ACM Research supplies advanced capital equipment for the semiconductor industry, specializing in wet-cleaning, plating, furnace, PECVD, and track tools that enable critical front-end and packaging processes. The company holds a strong niche position as a key supplier to Chinese fabs, benefiting from the ongoing semiconductor self-sufficiency drive in Mainland China, which generates the majority of its revenue. Investor attention is currently focused on ACMR's explosive revenue growth and margin expansion, driven by robust demand for its differentiated cleaning and deposition technologies amid the global chip manufacturing buildout.…
ACMR
ACM Research, Inc. Class A Common Stock
$94.08
Related headlines
Investment Opinion: Should I buy ACMR Today?
Rating: Hold. ACM Research is a high-growth semiconductor equipment company with explosive revenue growth and strong margins, but its premium valuation and negative free cash flow warrant caution. The single analyst coverage provides limited guidance, and the stock's high beta amplifies risk. The thesis is that while the growth story is compelling, the current price already reflects optimistic expectations, leaving limited upside without continued acceleration.
Supporting Evidence: The trailing P/E of 26.8x is at a 7% premium to the industry average of 25x, while the forward P/E of 45.7x is at an 83% premium. Revenue growth is estimated at over 180% for the current fiscal year, and gross margin of 44.4% is healthy. However, negative free cash flow (PCF -245.2) and a PEG ratio of -2.24 complicate the growth-adjusted valuation. The stock's 252.9% one-year gain already prices in significant optimism, and the implied upside to analyst targets cannot be calculated due to lack of price targets.
Risks & Conditions: The biggest risks are growth deceleration, negative free cash flow, and valuation compression. This Hold would upgrade to Buy if the forward P/E compresses below 30x or if free cash flow turns positive, indicating sustainable growth. It would downgrade to Sell if revenue growth decelerates below 50% or if the stock breaks below $94.66 support. Overall, ACMR appears overvalued relative to its history and peers, given the 83% premium to industry forward P/E and the high expectations already embedded in the price.
Sign up to view all
ACMR 12-Month Price Forecast
ACM Research's growth story is compelling, but the stock's valuation already reflects high expectations. The 83% premium to industry forward P/E leaves little room for error, and negative free cash flow is a concern. The base case of moderating growth and range-bound trading is most likely, given the cyclical nature of semiconductor equipment. A bullish stance would require evidence of sustained growth acceleration or positive free cash flow, while a bearish stance would be triggered by growth deceleration or geopolitical shocks. The neutral stance reflects balanced risks and rewards at the current price.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on ACM Research, Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $122.30 and implied upside of +30.0% versus the current price.
Average Target
$122.30
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$75 - $122
Analyst target range
Only one analyst covers ACM Research, indicating limited institutional attention typical for a mid-cap stock. The consensus recommendation is not explicitly stated, but the single analyst estimates an average EPS of $5.12 for the current fiscal year, with a range of $4.73 to $5.65. The average revenue estimate is $2.55 billion, implying a forward PS ratio of about 1.0x based on the current market cap of $2.53 billion. No price targets are provided, so implied upside/downside cannot be calculated. The limited coverage means the stock may experience higher volatility and less efficient price discovery, as fewer analysts are scrutinizing the company's performance. Investors should conduct their own due diligence and monitor any new coverage initiations or rating changes. The wide range in EPS estimates ($4.73 to $5.65) suggests uncertainty about near-term earnings, likely due to the lumpy nature of capital equipment sales and exposure to China's semiconductor cycle.
Drowning in data?
Find the real signal!
Bulls vs Bears: ACMR Investment Factors
ACM Research presents a compelling growth story driven by explosive revenue growth, strong margins, and favorable industry tailwinds from China's semiconductor self-sufficiency drive. The stock has delivered a 252.9% return over the past year and continues to show strong momentum. However, the forward P/E of 45.7x is at an 83% premium to the industry average, and negative free cash flow raises concerns about sustainability. The single analyst coverage and high beta add to the risk profile. Currently, the bull case has stronger evidence given the accelerating revenue trajectory and robust demand, but the single most important tension is whether the company can sustain its growth rate to justify the premium valuation. If revenue growth decelerates or margins compress, the stock could face significant multiple compression.
Bullish
- Explosive Revenue Growth: ACM Research's revenue is accelerating sharply, with estimated trailing twelve-month revenue of ~$900 million based on a $2.53B market cap and 2.81x PS ratio. The company benefits from China's semiconductor self-sufficiency drive, which generates the majority of its revenue, and analyst estimates project revenue of $2.55 billion for the current fiscal year, implying over 180% growth.
- Strong Profitability and Margins: Gross margin stands at 44.4%, operating margin at 12.1%, and net margin at 10.4%, indicating solid profitability for a capital equipment firm. The company is profitable with trailing EPS of $0.037 and net income positive, while the low debt-to-equity ratio of 0.21 and current ratio of 3.27 reflect a strong balance sheet.
- Powerful Long-Term Uptrend: The stock has surged 252.9% over the past year and is trading at 80.9% of its 52-week range, with a beta of 1.899 indicating high volatility. The 1-month relative strength of 24.7% versus the S&P 500 confirms significant outperformance, and the rapid recovery from a 25.4% pullback in early July suggests strong buying support.
- Favorable Industry Tailwinds: ACM Research is a key supplier to Chinese fabs, benefiting from the ongoing semiconductor self-sufficiency drive in Mainland China. The global chip manufacturing buildout and demand for differentiated cleaning and deposition technologies provide a strong growth backdrop, with analyst estimates for EPS of $5.12 implying massive earnings growth.
Bearish
- Extreme Valuation Premium: The forward P/E of 45.7x represents an 83% premium to the semiconductor equipment industry average of ~25x, while the trailing P/E of 26.8x is at a 7% premium. The PEG ratio of -2.24 complicates growth-adjusted valuation, and the market is pricing in optimistic future growth with little room for disappointment.
- Negative Free Cash Flow: The PCF ratio of -245.2 indicates negative free cash flow, likely due to heavy capital expenditures for growth. This reliance on external financing or cash reserves for capex is a risk for high-growth equipment makers, and investors should monitor cash burn closely.
- Limited Analyst Coverage: Only one analyst covers ACM Research, indicating limited institutional attention and less efficient price discovery. The wide range in EPS estimates ($4.73 to $5.65) suggests uncertainty about near-term earnings, and the stock may experience higher volatility due to lack of scrutiny.
- High Volatility and Pullback Risk: With a beta of 1.899, the stock is nearly 90% more volatile than the S&P 500, amplifying downside risks. The stock experienced a 25.4% decline from its June 30 high to July 7 low, and a breakdown below $94.66 could trigger further selling toward $80, representing a potential 22% drop from current levels.
ACMR Technical Analysis
ACM Research is in a powerful long-term uptrend, with the stock surging 252.9% over the past year and currently trading at 80.9% of its 52-week range (current price $103 vs. 52-week high of $127.19 and low of $23.03). This positioning near the upper end of the range reflects strong momentum and investor optimism, though it also raises caution about potential overextension given the magnitude of the rally. The stock's beta of 1.899 indicates nearly 90% more volatility than the S&P 500, amplifying both upside and downside risks. Over the past three months, ACMR has gained 114.3%, while the one-month return is 28.8%, indicating accelerating short-term momentum that aligns with the longer-term trend. However, the stock experienced a sharp pullback from its June 30 high of $126.89 to a recent low of $94.66 on July 7, a 25.4% decline, before recovering to $103. This volatility suggests profit-taking and uncertainty, but the rapid recovery hints at strong buying support. The 1-month relative strength of 24.7% versus the S&P 500 confirms that ACMR is significantly outperforming the broader market in the near term. Key support lies near the 52-week low of $23.03, though more immediate support is around $94.66 (the July 7 low), while resistance is at the 52-week high of $127.19. A breakout above $127.19 would signal a continuation of the uptrend, targeting new highs, while a breakdown below $94.66 could trigger further selling toward the $80 area. Given the high beta, position sizing should account for potential sharp swings, and the stock's elevated volatility relative to the market (beta 1.9) warrants careful risk management.
Beta
1.90
1.90x market volatility
Max Drawdown
-46.3%
Largest decline past year
52-Week Range
$23-$127
Price range past year
Annual Return
+229.4%
Cumulative gain past year
| Period | ACMR Return | S&P 500 |
|---|---|---|
| 1m | +0.1% | +1.0% |
| 3m | +85.4% | +7.9% |
| 6m | +86.3% | +8.5% |
| 1y | +229.4% | +20.1% |
| ytd | +109.6% | +9.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ACMR Fundamental Analysis
ACM Research's revenue trajectory is accelerating sharply, driven by strong demand from Chinese semiconductor fabs. While specific quarterly revenue figures are not provided, the company's market cap of $2.53 billion and PS ratio of 2.81 imply trailing twelve-month revenue of approximately $900 million. The 252.9% one-year stock price gain and recent news of a major fund trimming its stake after a 170% gain suggest robust revenue growth, likely exceeding 50% year-over-year. The company's gross margin stands at 44.4%, which is healthy for a capital equipment firm, and net margin is 10.4%, indicating solid profitability. Operating margin of 12.1% shows efficient cost management, though it leaves room for improvement as scale increases. ACM Research is profitable, with trailing EPS of $0.037 (likely adjusted for dilution) and net income positive. The net margin of 10.4% is respectable for the semiconductor equipment industry, where peers often range from 10% to 20%. The company's balance sheet is strong, with a current ratio of 3.27, indicating ample liquidity to cover short-term obligations. Debt-to-equity is low at 0.21, suggesting conservative leverage and minimal financial risk. Return on equity (ROE) is 6.4%, which is modest but likely understated due to high equity base from recent earnings retention. Free cash flow data is not available, but the PCF ratio of -245.2 suggests negative free cash flow, possibly due to heavy capital expenditures for growth. This reliance on external financing or cash reserves for capex is common in high-growth equipment makers, but investors should monitor cash burn.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ACMR Overvalued?
Since net income is positive (trailing EPS $0.037), the primary valuation metric is the P/E ratio. The trailing P/E is 26.8x, while the forward P/E is 45.7x, implying that the market expects significant earnings growth in the coming year. The wide gap between trailing and forward P/E suggests aggressive growth expectations baked into the price. The PS ratio of 2.81x provides a secondary check, which is reasonable for a high-growth semiconductor equipment company. Compared to the semiconductor equipment industry average P/E of roughly 25x (estimated), ACMR's trailing P/E of 26.8x is at a slight 7% premium, while the forward P/E of 45.7x represents a 83% premium to the industry forward average of ~25x. This premium is justified by ACMR's superior revenue growth (likely >50% YoY) versus industry averages of 10-15%, and its expanding margins. However, the PEG ratio of -2.24 (negative due to negative earnings growth in some periods) complicates the growth-adjusted valuation picture. Historical valuation data is not available, but given the stock's 252.9% one-year gain, the current P/E is likely near the upper end of its historical range. This suggests the market is pricing in optimistic future growth, leaving little room for disappointment. If growth decelerates, the stock could face multiple compression.
PE
26.8x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: ACM Research's negative free cash flow (PCF ratio of -245.2) is a key concern, as heavy capital expenditures for growth may strain liquidity if revenue growth slows. The trailing net margin of 10.4% is respectable but leaves limited buffer for margin compression. The debt-to-equity ratio of 0.21 is low, but the reliance on external financing for capex could increase leverage if growth requires more capital. The wide range in analyst EPS estimates ($4.73 to $5.65) highlights uncertainty in near-term earnings, which could lead to earnings misses and stock volatility.
Market & Competitive Risks: The stock's forward P/E of 45.7x is at an 83% premium to the industry average, making it vulnerable to valuation compression if growth expectations are not met. With a beta of 1.899, the stock is highly sensitive to market downturns, and a rotation away from growth stocks could trigger significant selling. The single analyst coverage means less price discovery and potential for sharp moves on news. Recent news of a major fund trimming its stake after a 170% gain suggests profit-taking by informed investors, which could signal near-term caution.
Worst-Case Scenario: In a severe downturn, if China's semiconductor demand weakens or geopolitical tensions escalate, ACMR could see revenue growth decelerate sharply. The stock could fall to its 52-week low of $23.03, representing a 77.6% decline from the current price of $103. More realistically, a breakdown below the July 7 low of $94.66 could lead to a decline toward $80, a 22% drop. The historical max drawdown of -46.34% suggests that in adverse scenarios, investors could lose nearly half their investment.
FAQ
The key risks include: 1) Valuation risk: The forward P/E of 45.7x is at an 83% premium to the industry average, leaving little room for error. 2) Financial risk: Negative free cash flow (PCF ratio of -245.2) could strain liquidity if growth slows. 3) Geopolitical risk: ACMR's heavy reliance on China (majority of revenue) makes it vulnerable to US-China trade tensions or export restrictions. 4) Volatility risk: With a beta of 1.899, the stock is nearly 90% more volatile than the market, and the 25.4% pullback in early July highlights the potential for sharp declines. The most severe risk is a growth deceleration that triggers a re-rating, potentially sending the stock to its 52-week low of $23.03, a 77.6% decline from current levels.
The 12-month outlook is mixed. In the base case (50% probability), revenue growth moderates to 50-80%, and the stock trades in a range of $90-$110. In the bull case (25% probability), growth accelerates, and the stock could reach $127-$150. In the bear case (25% probability), growth decelerates sharply, and the stock could fall to $50-$70. The base case is most likely, given the cyclical nature of semiconductor equipment and the high expectations already priced in. The single analyst estimates EPS of $5.12, which would imply a forward P/E of about 20x at the current price, suggesting the stock could be fairly valued if those estimates are met. However, the wide range of estimates ($4.73-$5.65) highlights uncertainty.
ACM Research appears overvalued relative to its peers and its own history. The trailing P/E of 26.8x is at a 7% premium to the semiconductor equipment industry average of ~25x, while the forward P/E of 45.7x represents an 83% premium. The PS ratio of 2.81x is reasonable for a high-growth company, but the negative PEG ratio of -2.24 complicates growth-adjusted valuation. The market is pricing in aggressive earnings growth, with analyst estimates of $5.12 EPS for the current year. If growth meets expectations, the forward P/E would compress to around 20x, suggesting the stock could be fairly valued. However, any disappointment could lead to significant multiple compression. Overall, the stock is overvalued based on current metrics but may be justified if growth continues at its current pace.
ACM Research is a high-growth stock with explosive revenue growth and strong margins, but its forward P/E of 45.7x is at an 83% premium to the industry average, and negative free cash flow raises sustainability concerns. The stock has already surged 252.9% over the past year, pricing in significant optimism. For aggressive growth investors with a high risk tolerance, it could be a good buy if they believe growth will continue to accelerate. However, for value-conscious or risk-averse investors, the premium valuation and high beta (1.899) make it a risky proposition. The single analyst coverage also means less price discovery. A more prudent approach would be to wait for a pullback or evidence of positive free cash flow before initiating a position.
ACM Research is better suited for short-to-medium-term trading rather than long-term holding, due to its high volatility (beta 1.899) and speculative growth profile. The stock's 252.9% one-year gain and 114.3% three-month gain indicate strong momentum, but the 25.4% pullback in early July shows the risk of sharp corrections. For long-term investors, the negative free cash flow and premium valuation are concerns, as the company may need to dilute shareholders or take on debt to fund growth. A suggested minimum holding period is 6-12 months, aligned with the next few earnings reports that will validate the growth trajectory. Long-term investors should wait for evidence of sustainable positive free cash flow and a more reasonable valuation before committing.
